You are currently logged into
Cancer Health Directory - My Account or Log Out
Cancer Health Cancer Health
  • Home
  • News
    • News
    • Newsfeed
    • Science News
    • Features
    • Opinions
    • Conferences
    • Slideshows
    • Cancer Health TV
    • By Author
    • RSS Links
  • Cancer Basics
    • Cancer 101
    • Newly Diagnosed
    • Living with Cancer
    • Cancer Treatment
    • Cancer Medications
    • Breast Cancer
    • Colon Cancer
    • Liver Cancer
    • Lung Cancer
    • Prostate Cancer
    • More Types of Cancer
    • Resources
  • Hot Topics
    • Coronavirus (COVID-19)
    • Health Equity
    • Cancer Treatment
    • Car-T Therapy
    • Caregivers
    • Chemotherapy
    • Immunotherapy
    • Marijuana
    • Mental Health
    • Quality of Life
  • Magazine
    • Magazine
    • Current Issue
    • Archives
    • Digital Editions
    • Cancer Health Focus
    • Bulk Subscriptions
    • Email Newsletters
  • Blogs
    • Blogs
    • Recent Posts
    • Browse Bloggers
    • RSS Links
  • Community
    • Cancer Health Stories
    • Cancer Health Forums
    • Ask Cancer Health
    • Polls
    • Surveys
    • Quizzes
    • Calendar
    • Volunteer Jobs
    • Bookstore
    • Amazon Store
  • About Us
    • About Us
    • Masthead
    • Advertise
    • Awards
    • Contact Us
  • Facebook
  • Twitter

© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2021 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement

Share


Twitter
Facebook
Pinterest
Tumblr
Email

#Amgen

Tweet
  • Share

KRAS Blocker Sotorasib Delays Lung Cancer Progression

The drug also showed promise for colorectal and other cancers, but it might work better in combination regimens.

Second KRAS Inhibitor Shows Promise in Early Study

MRTX849 shrank tumors in half of lung cancer patients with a common but difficult to target mutation.

Hitting an Elusive Target

First KRAS targeted therapy shows promise for lung and colon cancer

More Good Results for KRAS Targeted Therapy for Lung Cancer

Half of study participants treated with AMG 510 saw their tumors shrink, and only one experienced disease progression.

Celebrating 10 Years of Collaboration to Prevent Infections in Cancer Patients

I understand how people dealing with a cancer diagnosis are incredibly overwhelmed with information.

KRASG12C inhibitor AMG 510

First KRAS Targeted Therapy Shows Promise for Lung and Colon Cancer

AMG 510 shrank tumors in half of lung cancer patients with a mutation thought to be “undruggable.”

Cancer cells and lymphocytes

Immune Profile for Successful Cancer Immunotherapy Discovered

Multiple immune cell types must be present in tumors for checkpoint inhibitor therapies to be effective.

Advertisement

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.